Pharmafile Logo

Glaucoma in perspective

- PMLiVE

Interview: Harvey Berger and Timothy Clackson, Ariad

Ariad’s CEO and president of R&D talk about following their own path in oncology

- PMLiVE

Teva cuts 5,000 jobs to save $2bn a year by 2017

Israeli pharma company accelerates cost-reduction plans

- PMLiVE

Pfizer calls for mHealth to be prioritised

Wants more action to support mobile health in developing countries' ageing populations

- PMLiVE

AstraZeneca/J&J form Japanese cancer partnership

Two companies will co-promote Zytiga in prostate cancer

PSI appoints new country manager for Germany

Sabine Debuschewitz will be based at the CRO's Munich office

- PMLiVE

Xeljanz effective in psoriasis says Pfizer

Data backs extension of drug’s indications

- PMLiVE

A breath of fresh air

Is the ‘freshness index’ a valuable tool for measuring a company’s innovation?

- PMLiVE

IQWiG: Key data missing from public trial reports

German HTA body claims drug studies published in journals contain ”insufficient information"

- PMLiVE

Ariad halts patient enrolment for cancer drug studies

Concerns raised after patients taking Iclusig experience blood clots and cardiovascular events

- PMLiVE

Gilead halts leukaemia study on positive results

Idelalisib provides significant benefit in chronic lymphocytic leukaemia

- PMLiVE

New faces at Red Door

Suzanne Walsh, Georgina Grant and Abigail Thomson appointed senior account managers at comms firm

ABPI London offices

ABPI announces review of Code

Trade body to update standards for pharma industry in UK

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links